<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01634867</url>
  </required_header>
  <id_info>
    <org_study_id>2012-03</org_study_id>
    <nct_id>NCT01634867</nct_id>
  </id_info>
  <brief_title>Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access in Pediatric Patients</brief_title>
  <official_title>A Pilot Study of Intubating Conditions Comparing Intraosseous Vascular Access With Peripheral Intravenous Access for Drug Delivery in Rapid Sequence Intubation Using Rocuronium as the Paralytic Agent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vidacare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vidacare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate using intraosseous vascular access and intravenous vascular access
      to give pediatric patients the necessary medications to perform rapid sequence intubation,
      for patients with airway difficulties.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No subject enrollment.
  </why_stopped>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time from determination of need for vascular access for rapid sequence intubation to administration of first does of paralytic agent.</measure>
    <time_frame>during rapid sequence intubation procedure, average expected time frame 30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time from vascular access to intubation first attempt, as indicated by the first attempt to visualize the larynx with the laryngoscope.</measure>
    <time_frame>during rapid sequence intubation procedure, average expected time frame 30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>time from vascular access to successful intubation</measure>
    <time_frame>during rapid sequence intubation procedure, average expected time frame 30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>number of attempts necessary for successful intubation</measure>
    <time_frame>during rapid sequence intubation procedure, average expected time frame 30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubation difficulty</measure>
    <time_frame>during rapid sequence intubation procedure, average time frame 30 minutes</time_frame>
    <description>The Intubation Difficulty Scale is a validated tool used to grade the difficulty with which a patient was intubated for airway managment during rapid sequence intubation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operator satisfaction with intubating conditions</measure>
    <time_frame>during rapid sequence intubation procedure, average time frame 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>failure rate of endotracheal intubation</measure>
    <time_frame>during rapid sequence intubation procedure, average time frame 30 minutes</time_frame>
    <description>failure rate of endotracheal intubation and requirement for alternative airway management.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from presentation of patient to vascular access established</measure>
    <time_frame>during rapid sequence intubation procedure, average time frame 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the incidence of short term catheter related complications for each technique</measure>
    <time_frame>during emergency department stay, average time frame 24 hours</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Airway Control</condition>
  <arm_group>
    <arm_group_label>Intraosseous (IO) drug delivery</arm_group_label>
    <description>patients in whom intraosseous (IO) vascular access has been established for rapid sequence intubation drug delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peripheral intravenous (IV) drug delivery</arm_group_label>
    <description>patients in whom peripheral intravenous (IV) vascular access has been established for rapid sequence intubation drug delivery.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients in the emergency department with airway difficulties requiring rapid sequence
        intubation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects requiring rapid sequence intubation for whom rocuronium is chosen as the
             paralytic agent.

          -  the operator chooses to place a peripheral intravenous or powered intraosseous
             catheter to permit rapid sequence intubation.

        Exclusion Criteria:

          -  subjects in whom vascular access for rapid sequence intubation drug administration was
             established prior to arrival to the emergency department.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward Truemper, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nebraska</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Omaha Children's Hospital and Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Reades R, Studnek JR, Vandeventer S, Garrett J. Intraosseous versus intravenous vascular access during out-of-hospital cardiac arrest: a randomized controlled trial. Ann Emerg Med. 2011 Dec;58(6):509-16. doi: 10.1016/j.annemergmed.2011.07.020.</citation>
    <PMID>21856044</PMID>
  </reference>
  <reference>
    <citation>Adnet F, Borron SW, Racine SX, Clemessy JL, Fournier JL, Plaisance P, Lapandry C. The intubation difficulty scale (IDS): proposal and evaluation of a new score characterizing the complexity of endotracheal intubation. Anesthesiology. 1997 Dec;87(6):1290-7.</citation>
    <PMID>9416711</PMID>
  </reference>
  <reference>
    <citation>Leidel BA, Kirchhoff C, Bogner V, Braunstein V, Biberthaler P, Kanz KG. Comparison of intraosseous versus central venous vascular access in adults under resuscitation in the emergency department with inaccessible peripheral veins. Resuscitation. 2012 Jan;83(1):40-5. doi: 10.1016/j.resuscitation.2011.08.017. Epub 2011 Sep 3.</citation>
    <PMID>21893125</PMID>
  </reference>
  <reference>
    <citation>Deakin CD, Nolan JP, Soar J, Sunde K, Koster RW, Smith GB, Perkins GD. European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support. Resuscitation. 2010 Oct;81(10):1305-52. doi: 10.1016/j.resuscitation.2010.08.017. Erratum in: Resuscitation. 2011 Jan;82(1):140.</citation>
    <PMID>20956049</PMID>
  </reference>
  <reference>
    <citation>Kleinman ME, de Caen AR, Chameides L, Atkins DL, Berg RA, Berg MD, Bhanji F, Biarent D, Bingham R, Coovadia AH, Hazinski MF, Hickey RW, Nadkarni VM, Reis AG, Rodriguez-Nunez A, Tibballs J, Zaritsky AL, Zideman D; Pediatric Basic and Advanced Life Support Chapter Collaborators. Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2010 Oct 19;122(16 Suppl 2):S466-515. doi: 10.1161/CIRCULATIONAHA.110.971093.</citation>
    <PMID>20956258</PMID>
  </reference>
  <reference>
    <citation>Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009 Feb;37(2):666-88. doi: 10.1097/CCM.0b013e31819323c6. Erratum in: Crit Care Med. 2009 Apr;37(4):1536. Skache, Sara [corrected to Kache, Saraswati]; Irazusta, Jose [corrected to Irazuzta, Jose].</citation>
    <PMID>19325359</PMID>
  </reference>
  <reference>
    <citation>Von Hoff DD, Kuhn JG, Burris HA 3rd, Miller LJ. Does intraosseous equal intravenous? A pharmacokinetic study. Am J Emerg Med. 2008 Jan;26(1):31-8.</citation>
    <PMID>18082778</PMID>
  </reference>
  <reference>
    <citation>Orlowski JP, Porembka DT, Gallagher JM, Lockrem JD, VanLente F. Comparison study of intraosseous, central intravenous, and peripheral intravenous infusions of emergency drugs. Am J Dis Child. 1990 Jan;144(1):112-7.</citation>
    <PMID>1688484</PMID>
  </reference>
  <reference>
    <citation>Laurin EG, Sakles JC, Panacek EA, Rantapaa AA, Redd J. A comparison of succinylcholine and rocuronium for rapid-sequence intubation of emergency department patients. Acad Emerg Med. 2000 Dec;7(12):1362-9.</citation>
    <PMID>11099426</PMID>
  </reference>
  <reference>
    <citation>Perry JJ, Lee JS, Sillberg VA, Wells GA. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD002788. doi: 10.1002/14651858.CD002788.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;10:CD002788.</citation>
    <PMID>18425883</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2012</study_first_submitted>
  <study_first_submitted_qc>July 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2012</study_first_posted>
  <last_update_submitted>December 19, 2014</last_update_submitted>
  <last_update_submitted_qc>December 19, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

